跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
双伟 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Compound Paracetamol and Amantadine Hydrochloride Capsules
Approved
化学药品
Compound Paracetamol and Amantadine Hydrochloride Capsules
宁波双伟制药有限公司
🇨🇳 National Medical Products Administration
Approval Date
Apr 28, 2020
Approval ID
7LeafeOWpyp
Company
宁波双伟制药有限公司
Type
化学药品
Approval Details
Approval Id
7LeafeOWpyp
Approval Number
国药准字H33020417
Generic Name
复方氨酚烷胺胶囊
Generic Name En
Compound Paracetamol and Amantadine Hydrochloride Capsules
Brand Name
双伟
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
对乙酰氨基酚0.25g,盐酸金刚烷胺0.1g
Reg Date
2020-04-28
Company Name
宁波双伟制药有限公司
Production Company Name
宁波双伟制药有限公司
Production Company Address
宁波市宁海城关竹泉路(科技工业园区)
Company Detail Path
/organization/zhu-bo-shuang-wei-zhi-yao-you-xian-gong-si
Production Company Detail Path
/organization/zhu-bo-shuang-wei-zhi-yao-you-xian-gong-si
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Apr 28, 2020
Approval ID
7LeafeOWpyp
Type
化学药品
Back to NMPA Approvals